0001362118-21-000051.txt : 20211207 0001362118-21-000051.hdr.sgml : 20211207 20211207155226 ACCESSION NUMBER: 0001362118-21-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20211207 DATE AS OF CHANGE: 20211207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Velge Bertrand CENTRAL INDEX KEY: 0001758339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 211475925 MAIL ADDRESS: STREET 1: BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND STREET 2: ROMNEY MARSH CITY: KENT STATE: X0 ZIP: TN299TR ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-09-30 0 0000948320 LifeMD, Inc. LFMD 0001758339 Velge Bertrand C/O LIFEMD, INC. 800 THIRD AVE STE 2800 NEW YORK NY 10022 1 0 0 0 Common Stock 217391 D Common Stock 2020-04-15 4 P 0 294118 0.17 A 511509 D Common Stock 2020-08-05 4 A 0 173234 0 A 684743 D Common Stock 2020-09-22 4 P 0 96923 0.65 A 781666 D Common Stock 2021-12-03 4 P 0 110000 3.91 A 891666 I By Aliunde LLC Warrants to Purchase Common Stock 0.28 2019-05-15 2023-05-15 Common Stock 217391 217391 D Stock Option (Right to Buy) 1.15 2019-09-30 4 A 0 2500 0 A 2019-09-30 2024-09-30 Common Stock 2500 2500 D Stock Option (Right to Buy) 1.15 2019-12-31 4 A 0 2500 0 A 2019-12-31 2024-12-31 Common Stock 2500 2500 D Stock Option (Right to Buy) 1.2 2020-03-31 4 A 0 2500 0 A 2021-03-31 2025-03-31 Common Stock 2500 2500 D Stock Option (Right to Buy) 1.5 2020-06-30 4 A 0 2500 0 A 2020-06-30 2025-06-30 Common Stock 2500 2500 D Warrants to Purchase Common Stock 4.65 2020-09-22 4 A 0 100000 0 A 2020-09-22 2024-09-22 Common Stock 100000 100000 D Stock Option (Right to Buy) 7.95 2020-09-30 4 A 0 2500 0 A 2020-09-30 2025-09-30 Common Stock 2500 2500 D Stock Option (Right to Buy) 7 2020-12-31 4 A 0 2500 0 A 2020-12-31 2025-12-31 Common Stock 2500 2500 D Stock Option (Right to Buy) 11.98 2021-03-31 4 A 0 2500 0 A 2021-03-31 2026-03-31 Common Stock 2500 2500 D Stock Option (Right to Buy) 11.56 2020-06-30 4 A 0 2500 0 A 2021-06-30 2026-06-30 Common Stock 2500 2500 D On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt. Issued as director's compensation. Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019. /s/ Bertrand Velge 2021-12-07